503B compounding

Cooperation among 503A and 503B compounders will be needed to navigate dangerous regulatory shoals in 2025, experts ...

MAY 19, 2025

Most health-system pharmacies will outsource at least some of their sterile product compounding, but 503B vendors ...

MARCH 14, 2025

Drug compounding facilities should be allowed to produce products beyond the FDA’s current hard compounding ...

NOVEMBER 19, 2024

With drug shortages at an all-time high, hospital and health-system pharmacies are increasingly turning to 503B ...

JULY 26, 2024

Your health-system pharmacy has decided to partner with a new 503B sterile compounding outsourcing facility, or the ...

JUNE 19, 2024

SSM Health was the first health system in the nation to establish its own 503B compounding facility. Its recent ...

MARCH 4, 2024

Difficult-to-compound medications, outsourcing guidelines and a new draft guidance on the bulk drug substance lists ...

DECEMBER 27, 2023

Duke University Health System has been doing bulk nonsterile compounding since well before there was a USP Chapter ...

NOVEMBER 29, 2023

SSM Health, one of the largest health systems in the nation with 23 hospitals in Illinois, Missouri, Oklahoma and ...

NOVEMBER 7, 2023

503B drug compounding facilities, community pharmacists, drug manufacturers, and other stakeholders are debating ...

OCTOBER 10, 2023

Leiters announced that it is rebranding the company to better represent its growing market leadership in healthcare ...

JULY 3, 2023

The 110,000-square-foot facility was previously used to manufacture prescription products, including sterile ...

FEBRUARY 10, 2022